Endothelin Receptor Blockade in Heart Failure With Diastolic Dysfunction and Pulmonary Hypertension.
Phase of Trial: Phase III
Latest Information Update: 01 Aug 2014
At a glance
- Drugs Bosentan (Primary)
- Indications Heart failure; Pulmonary hypertension
- Focus Therapeutic Use
- Acronyms BADDHY
- 10 Jun 2017 Biomarkers information updated
- 27 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Jan 2010 Additional trial lead investigator identified as reported by ClinicalTrials.gov.